Traditional Chinese medicine for treating schizophrenia and preparation method thereof

Abstract

The invention provides a traditional Chinese medicine for treating schizophrenia and a preparation method thereof. The traditional Chinese medicine comprises the following raw herbal materials: cladonia fallax abbayes, berchemia lineate, uncaria rhynchophylla root, jasmine, fermented soybean, scutellaria baicalensis, square-stem, folium mori, angelica sinensis, rhizoma cyperi, semen cassia, scouring rush, dogwood, semen celosiae, pipewort, butterflybush flower, motherwort fruit, fructus trichosanthis, bamboo shavings, bamboo juice, tabasheer, magnetite, medicated leaven, keel, valerian, polygala tenuifolia, cortex albiziae, concha mauritiae arabicae, liquorice and rhizoma acori graminei. The traditional Chinese medicine has the beneficial effects that the traditional Chinese medicine disclosed by the invention adopts different properties of traditional Chinese medicinal materials, is rigorous in compatibility, can directly reach the focus of infection by treatment based on syndrome differentiation, has the effects of purging liver-fire, and removing phlegm and inducing resuscitation, is short in recovery time, not easy to reappear after recovery, small in toxic and side effects, proper in taste, easy to accept by a patient, and simple and convenient in manufacturing process; the drug is easy to manufacture and low in cost.

Description

[0001] technical field [0002] The invention relates to the technical field of pharmacy, in particular to a traditional Chinese medicine for treating schizophrenia and a preparation method thereof Background technique [0003] Schizophrenia is a group of severe mental illnesses of unknown etiology, mostly in young adults with slow or subacute onset, clinically manifested as a syndrome with various symptoms, involving obstacles in perception, thinking, emotion, and behavior and incoordination of mental activity. Patients generally have clear consciousness and basically normal intelligence, but some patients may experience cognitive impairment during the course of the disease. The course of the disease is generally protracted, showing recurrent attacks, aggravation or deterioration, and some patients eventually develop decline and mental disability, but some patients can maintain recovery or basically recovery after treatment. [0004] The basic causes mainly include the fo...

AI Technical Summary

Problems solved by technology

[0012] (4) Disorders of will and behavior: Most patients have decreased or even lack of will, manifested as reduced activities, being alone, passive behavior, and lack of due enthusiasm and initiative Sexuality, loss of interest in work and study, no concern for the future, no clear plans for the future, some patients may have some plans and intentions, but they are rarely implemented

[0020]2. Internal resistance of phlegm and dampness

[0040]At present, Western medicine treats schizophrenia, and antipsychotic drug treatment is the preferred treatment for schizophrenia. The curative effect is not good, and the treatment efficiency is low. It can only play a controlling role , Once the dose is insufficient or the drug is stopped, it will relapse, with relatively large side effects, strong dependence and drug resistance